61
Participants
Start Date
January 10, 2015
Primary Completion Date
August 8, 2024
Study Completion Date
March 11, 2025
Alemtuzumab
Alemtuzumab 0.2 mg/kg IV over 2 hours on days -10 to -6 from transplant.
Fludarabine
Fludarabine 40 mg/m2 IV over 1 hour on days -6 to -2 from transplant.
Cyclophosphamide
Cyclophosphamide 50 mg/kg IV over 2 hours on day -7 from transplant.
Total Body Irradiation
TBI 200 cGy as a single fraction on day -1 from transplant.
Stem Cell Transplant
Stem cell transplant on day 0.
Anti-thymocyte globulin
ATG (Thymoglobulin - Rabbit ) 3 mg/kg IV on days -5 to -3 from stem cell transplant.
University of Minnesota Medical Center, Fairview, Minneapolis
Masonic Cancer Center, University of Minnesota
OTHER